| Literature DB >> 33898032 |
Abstract
BACKGROUND: Estimation of parathyroid hormone (PTH) after thyroid surgery helps to predict the development of hypocalcemia and allows early intervention and management with oral calcium and/or vitamin D supplementation in the postoperative period. PATIENTS AND METHODS: This retrospective study included 57 patients who underwent total or completion thyroidectomy within 4 years. Measurement of serum PTH level was done 3 h after surgery for its change and prediction of hypocalcemia.Entities:
Keywords: Hypocalcemia; Hypoparathyroidism parathyroid hormone; PTH; Thyroidectomy
Year: 2021 PMID: 33898032 PMCID: PMC8058903 DOI: 10.1016/j.amsu.2021.102252
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Showing the characteristics of the patients who are involved in our study.
| Category (n = 57) | Number of patients | Percentage |
|---|---|---|
| 42.11 | 10.859 | |
| Male | 11 | 19.3 |
| Female | 46 | 80.7 |
| Total thyroidectomy | 51 | 89.5 |
| Completion thyroidectomy | 6 | 10.5 |
| MNG | 22 | 38.6 |
| PTC | 11 | 19.3 |
| Toxic MNG | 8 | 14.0 |
| Thyroiditis | 6 | 10.5 |
| Graves' disease | 5 | 8.8 |
| Recurrent MNG | 3 | 5.3 |
| Follicular carcinoma | 1 | 1.8 |
| Anaplastic thyroid cancer | 1 | 1.8 |
Abbreviations: MNG: multinodular goiter, PTC: papillary thyroid cancer.
Showing the postoperative serum levels of the parathyroid hormone and the calcium.
| Categories | Number of patients | Percentage |
|---|---|---|
| Normal (10–55 pg/ml) | 47 | 82.46 |
| Reduced (<10 pg/ml) | 10 | 17.54 |
| Normal (8.5–10.5 mg/dl) | 44 | 77.2 |
| Reduced (<8.4 mg/dl) | 13 | 22.8 |
Fig. 1A simple bar chart showing the percentages of patients who required postoperative supplementation with oral calcium and/or vitamin D.
Showing the correlation between the serum PTH 3 h after surgery and different patient characteristics.
| Serum PTH 3 h after surgery | Sig. (2-sided) | ||
|---|---|---|---|
| Normal (n = 47) | Reduced (n = 10) | ||
| 0.059* | |||
| Male | 7 (14.9%) | 6 (40%) | |
| Female | 40 (85.1%) | 4 (60%) | |
| 0.237* | |||
| Total thyroidectomy | 43 (91.5%) | 8 (80%) | |
| Completion thyroidectomy | 4 (8.5%) | 2 (20%) | |
| 0.000* | |||
| Normal | 41 (93.2%) | 0 (0.0%) | |
| Reduced | 3 (6.8%) | 13 (100.0%) | |
| 0.166* | |||
| MNG | 21 (43.8%) | 1 (11.1%) | |
| Recurrent MNG | 3 (6.3%) | 0 (0.0%) | |
| Toxic MNG | 6 (12.6%) | 2 (22.2%) | |
| Graves' disease | 4 (8.3%) | 1 (11.1%) | |
| PTC | 8 (16.7%) | 3 (33.3%) | |
| Anaplastic thyroid cancer | 0 (0.0%) | 1 (11.1%) | |
| Thyroiditis | 5 (10.4%) | 1 (11.1%) | |
*Fischer Exact test.